The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy

Aim. To study the mechanisms, features of clinical manifestations and predicting of cardiotoxicity resulting from anthracycline chemotherapy.Material and methods. We examined 176 women with breast cancer who received anthracycline antibiotics as part of polychemotherapeutic (PCT) treatment. Patients...

Full description

Bibliographic Details
Main Authors:	A. T. Teplyakov, S. N. Shilov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, K. V. Kopeva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2019-03-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	кардиомиопатия, кардиотоксичность, антрациклины, химиотерапия, биомаркеры, натрийуретические петиды, fas-лиганд, прогноз
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/749

Similar Items

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Ischemic stroke as the first manifestation of anthracycline cardiomyopathy
by: G. R. Ramazanov, et al.
Published: (2023-01-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data
by: L. Yu. Grivtsova, et al.
Published: (2020-12-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines
by: Alexandros Kouloubinis, et al.
Published: (2015-03-01)

Исследование кардиотоксичности у пациентов с онкологической патологией, получающих химиотерапию
by: С. Мелехов, et al.
Published: (2022-06-01)

РОЛЬ ПОЛИМОРФИЗМОВ ГЕНОВ TTN, TTN-TRUNCATION, ММР-2, ММР-3 В РАЗВИТИИ АНТРАЦИКЛИН-ИНДУЦИРОВАННОЙ КАРДИОМИОПАТИИ
by: I. A. Karputs, et al.
Published: (2021-05-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

EFFECT OF TRIMETAZIDINE ON MYOCARDIAL KARYOMETRY DURING THE DOXORUBICIN-CYCLOPHOSPHAMIDE MODE OF CHEMOTHERAPY PRESCRIPTION
by: Ашот Арманович Авагимян
Published: (2022-06-01)

Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy
by: V M Samoylenko, et al.
Published: (2006-03-01)

Heart failure in cancer patients
by: A. F. Khalirakhmanov, et al.
Published: (2022-01-01)

Нарушения ритма сердца у больных с онкологическими заболеваниями
by: Ульяна Александровна Григорьева
Published: (2021-10-01)

Four-year follow-up of a patient with mixed cardiomyopathy and an implanted cardiac contractility modulation device: a case report
by: T. M. Uskach, et al.
Published: (2021-09-01)

Farmorubitsin v klinicheskoy praktike
by: V A Gorbunova
Published: (2005-06-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Antitumour Drug Induced Cardiovascular Toxicity and Current Tumour Treatment Methods
by: K. S. Gumerova, et al.
Published: (2020-01-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
by: Ana Paula F. Bergantini, et al.
Published: (2005-06-01)

MODERN APPROACHES TO DETECTING EARLY SUBCLINICAL CARDIOTOXICITY INDUCED BY CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
by: A. A. Avalyan, et al.
Published: (2018-09-01)

Современные возможности эхокардиографии в диагностике кардиотоксического влияния химиотерапии
by: Татьяна Викторовна Найден, et al.
Published: (2020-12-01)

The In Situ Hybridization Expression of Fas and Fas Ligand (FasL) in Trophoblastic tissue of Aborted Women Compared with Normal Pregnancy.
by: Amal H. Salman, et al.
Published: (2009-07-01)

Serum Fas and Fas Ligand levels in childhood acute lymphoblastic leukemias
by: Ali Bülent Antmen, et al.
Published: (2019-12-01)

Expression of Fas and Fas-L in renal cell carcinoma
by: Govedarović Vitomir, et al.
Published: (2006-01-01)

The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct
by: Evgenij G. Furman, et al.
Published: (2019-04-01)

Çocukluk çağı akut lenfoblastik lösemilerde serum Fas ve Fas Ligand düzeyleri
by: Alev ARSLAN, et al.
Published: (2019-12-01)

Trabectedin – the DNA minor groove binder
by: G. A. Belitsky, et al.
Published: (2015-06-01)

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction
by: E. V. Grakova, et al.
Published: (2022-04-01)

Alteration of Regulation of Fas/FasL Mediated Apoptosis in Gastric Cancer
by: Reggie García Robles, et al.
Published: (2009-04-01)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
by: Ikomey George M, et al.
Published: (2012-06-01)

Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer
by: Jolanta Czyżewska, et al.
Published: (2011-04-01)

Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
by: A. Berdeli, et al.
Published: (2012-12-01)

LONG-TERM CARDIOVASCULAR COMPLICATIONS IN ONCOLOGIC PATIENTS AFTER ANTITUMOR THERAPY (>1 YEAR)
by: M. L. Kazantseva, et al.
Published: (2019-09-01)

PROTEASOMES AND EXOSOMES IN OVARIAN CANCER: RALATION WITH DISEASE PROGNOSIS AND CLINICAL OUTCOME
by: N. V. Yunusova, et al.
Published: (2016-02-01)

Plasma Levels of sFas-sFasL and <i>FASL</i> Gene Expression Are Associated with Tuberculosis
by: Iury de Paula Souza, et al.
Published: (2022-12-01)

Role of Fas/Fas Ligand Pathway in a Sample of Iraqi Diabetic Foot Patients
by: Sabah Khorsheed Hussian, et al.
Published: (2019-11-01)

Role of Fas/Fas Ligand Pathway in a Sample of Iraqi Diabetic Foot Patients
by: Sabah Khorsheed Hussian, et al.
Published: (2019-11-01)

Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck
by: Yu. V. Kostalanova, et al.
Published: (2020-11-01)

Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma
by: A. T. Teplyakov, et al.
Published: (2018-09-01)

Transfer of Fas (CD95) protein from the cell surface to the surface of polystyrene beads coated with anti-Fas antibody clone CH-11
by: H. Sawai, et al.
Published: (2010-02-01)